Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gynoflor vs Nitrofurantoin for Recurrent Cystitis in Postmenopausal Women
NCT07186465Phase 4Recruiting
- Sponsor
- Mahidol University
- Start
- Sep 2025
- Primary completion
- Jun 2026
- Modality
- Small Molecules, Live Biotherapeutic Products
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of Gynoflor in urinary tract infection (UTI) (2 arms), sponsored by Mahidol University. Primary endpoint: Proportion of participants with recurrent UTI at 6 months. Started Sep 2025; status: recruiting.
02
Drugs
Gynoflor
03
Conditions
urinary tract infection (UTI)
Beyond the preview
Go deeper on NCT07186465.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07186465.